SCHEMBL30903267

CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O

nearest known ligand 0.62

Predicted protein targets (top 9)

	gene	UniProt	supporting neighbours	confidence
▸	NPY2R	P49146	8/20	0.59

▸	NPY4R	P50391	8/20	0.59

▸	NPY5R	Q15761	8/20	0.59

▸	NPY1R	P25929	6/20	0.59

▸	CALCR	P30988	4/20	0.59

▸	TFPI	P10646	1/20	0.58

▸	GLP1R	P43220	4/20	0.58

▸	C5AR1	P21730	1/20	0.58

▸	GCGR	P47871	3/20	0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL29903219	0.92	NPY2R (0.66)	NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL30262233	0.90	CALCR (0.64)	NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL30906000	0.90	C5AR1 (0.58)	NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL31182486	0.90	CALCR (0.69)	NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL31182765	0.89	CALCR (0.62)	NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL30432128	0.89	CALCR (0.69)	NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL30511759	0.89	CALCR (0.66)	NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL30495793	0.89	CALCR (0.67)	NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL29695646	0.89	NPY2R (0.63)	NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL30658233	0.89	CALCR (0.71)	NPY2RNPY4RNPY5RNPY1RCALCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20240148849-A1	IMMUNOGENIC COMPOSITION, USE AND METHODS	GLAXOSMITHKLINE BIOLOGICALS SA (BE)	2024-05-09	—	—	US	disclosed